Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;9(1):139-57.
doi: 10.1007/s13311-011-0097-2.

Treatment of neuroterrorism

Affiliations
Review

Treatment of neuroterrorism

Katharina M Busl et al. Neurotherapeutics. 2012 Jan.

Abstract

Bioterrorism is defined as the intentional use of biological, chemical, nuclear, or radiological agents to cause disease, death, or environmental damage. Early recognition of a bioterrorist attack is of utmost importance to minimize casualties and initiate appropriate therapy. The range of agents that could potentially be used as weapons is wide, however, only a few of these agents have all the characteristics making them ideal for that purpose. Many of the chemical and biological weapons can cause neurological symptoms and damage the nervous system in varying degrees. Therefore, preparedness among neurologists is important. The main challenge is to be cognizant of the clinical syndromes and to be able to differentiate diseases caused by bioterrorism from naturally occurring disorders. This review provides an overview of the biological and chemical warfare agents, with a focus on neurological manifestation and an approach to treatment from a perspective of neurological critical care.

PubMed Disclaimer

References

    1. Greenfield RA, Brown BR, Hutchins JB, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. 2002;323:326–340. - PubMed
    1. Usamriid’s Medical Management of Biological Casualties Handbook. Woods, JB, lead editor. U.S. Army Medical Research, Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland; 2005.
    1. Keim M, Kaufmann AF. Principles for emergency response to bioterrorism. Ann Emerg Med. 1999;34:177–182. - PubMed
    1. Hupert N, Wattson D, Cuomo J, Benson S. Anticipating demand for emergency health services due to medication-related adverse events after rapid mass prophylaxis campaigns. Acad Emerg Med. 2007;14:268–274. - PubMed
    1. Emergency Preparedness and Response. Centers for Disease Control and Prevention, 2009, Atlanta, GA [cited 2011 March 1]; Available from: http://www.bt.cdc.gov/.